<DOC>
	<DOCNO>NCT02330965</DOCNO>
	<brief_summary>The primary goal study evaluate effect BAF312 ( siponimod ) select immune neuronal ( nerve ) cell examine laboratory specimen ( blood and/or spinal fluid ) multiple time point , prior , follow initiation BAF312 placebo treatment , patient Secondary Progressive Multiple Sclerosis ( SPMS ) enrol clinical trial ( NCT01665144 ) evaluate effectiveness safety BAF312 .</brief_summary>
	<brief_title>Mechanistic Studies Phase III Trial With BAF312 Secondary Progressive Multiple Sclerosis</brief_title>
	<detailed_description>This study complementary multi-center , randomize , double-blind , parallel-group , placebo-controlled , variable treatment duration study compare efficacy safety BAF312 placebo patient SPMS ( NCT01665144 ) . Investigators explore immunological neuroprotective mechanism BAF312 ( siponimod ) , novel agent set SPMS clinical trial . This study part multi-center study , University Michigan serve central site .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Multiple Sclerosis , Chronic Progressive</mesh_term>
	<criteria>Participants enrol multicenter , randomize , doubleblind , parallelgroup , placebocontrolled , variable treatment duration study compare efficacy safety BAF312 placebo patient Secondary Progressive Multiple Sclerosis ( SPMS ) Protocol No . CBAF312A2304 ( sponsor Novartis ) . Refer ClinicalTrials.gov record NCT01665144 . Subjects enrol one participate AMS04 study site locate United States . Subject must able provide write informed consent . Subjects severe bleed disorder , platelet count le ( &lt; ) 50,000/microliters ( Î¼L ) , and/or currently full anticoagulant therapy exclude optional CSF collection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>clinical research</keyword>
	<keyword>mechanistic study</keyword>
	<keyword>blood draw</keyword>
	<keyword>CSF lumbar puncture ( optional )</keyword>
</DOC>